Brief: Fusion Antibodies H1 Pretax Profit GBP -792 Thousand
19/11/2024 07:39
Nov 19 (Reuters) - Fusion Antibodies H1 revenue GBP 1.207 million. * H1 gross profit GBP 325 thousand * H1 EBIT GBP -794 thousand * H1 pretax profit GBP -792 thousand * H1 basic EPS GBP -0.8 * H1 net income GBP -758 thousand
Recent news on Fusion Antibodies
See all newsBrief: Fusion Antibodies Announces New TGE And Cryoem Project With US Pharma Client
Fusion Antibodies - Contract win
Fusion Antibodies - AGM statement H1 trading and research update
RCS - Fusion Antibodies - Launch of new customer-focused website
Fusion Antibodies - Posting of Annual Report & Notice of AGM